Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ur 12746

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ur 12746 in 4 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(ur 12746)
Trials
(ur 12746)
Recent Studies (post-2010) (ur 12746)
9,156187552623

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gálvez, J; Garrido, M; Merlos, M; Torres, MI; Zarzuelo, A1
Carceller, E; Escamilla, I; Ferrando, R; Forn, J; García-Rafanell, J; Giral, M; Merlos, M; Ramis, J; Salas, J1
de Medina, FS; Gálvez, J; Garrido, M; Merlos, M; Ramis, I; Rodríguez-Cabezas, ME; Zarzuelo, A1
Arribas, B; Bailón, E; Balsa, D; Camuesco, D; Comalada, M; Cueto-Sola, M; Gálvez, J; Garrido-Mesa, N; Janer, G; Merlos, M; Rodríguez-Cabezas, ME; Román, J; Xaus, J; Zarzuelo, A1

Other Studies

4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ur 12746

ArticleYear
Intestinal anti-inflammatory activity of UR-12746, a novel 5-ASA conjugate, on acute and chronic experimental colitis in the rat.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Acute Disease; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Aza Compounds; Chronic Disease; Colitis; Colon; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gastrointestinal Agents; Intestinal Mucosa; Intestines; Male; Mesalamine; Platelet Activating Factor; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sulfasalazine; Trinitrobenzenesulfonic Acid

2000
Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity.
    Journal of medicinal chemistry, 2001, Aug-30, Volume: 44, Issue:18

    Topics: Amines; Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aza Compounds; Azo Compounds; Colitis, Ulcerative; Drug Evaluation, Preclinical; Female; Hypotension; Imidazoles; Male; Mesalamine; Platelet Activating Factor; Platelet Aggregation; Prodrugs; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship; Trinitrobenzenesulfonic Acid

2001
The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production.
    Inflammatory bowel diseases, 2003, Volume: 9, Issue:6

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aza Compounds; Azo Compounds; Cell Line; Colitis; Colon; Cytokines; Down-Regulation; Female; Inflammation Mediators; Interleukin-1; Interleukin-8; Mesalamine; Neutrophil Infiltration; Peroxidase; Platelet Activating Factor; Rats; Rats, Wistar; Secondary Prevention; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2003
The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis.
    British journal of pharmacology, 2012, Volume: 165, Issue:3

    Topics: Aminosalicylic Acids; Animals; Anti-Inflammatory Agents; Aza Compounds; Azo Compounds; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Down-Regulation; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Platelet Activating Factor; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid

2012